(Ithaca, NY) — Halomine™, Inc., a pioneer in advanced technology for managing surfaces and providing long-term protection against viruses, bacteria, and fungi, is proud to announce that it has been ranked among the top 100 companies in The SOSV Human Health 100 portfolio. SOSV is an early-stage investor whose core mission is the advancement of human and planetary health. The aim of SOSV Human Health 100 is to showcase all the ways that the miraculous power of technology, guided by brilliant and relentless founders, is bettering human health.
Halomine was ranked because of its breakthrough advancements in the antimicrobial industry. Healthcare-associated infections and antibiotic-resistant infections are increasing worldwide. That increase, and the onset of the pandemic, has heightened concerns about dangerous pathogens and the limitations of current disinfecting solutions. Halomine is revolutionizing disinfection with its unique proprietary combinations of specialty molecules and polymers, customized to provide prolonged antimicrobial efficacy to a wide range of surfaces and materials.
Ted Eveleth, Halomine’s CEO, stated, “We are pleased and grateful to SOSV for the recognition of the extraordinary potential that Halomine’s technology has to provide antimicrobial protection to hospitals, public facilities, and consumer households”. Halomine’s mission is to provide a safer world from dangerous pathogens through state-of-the-art antimicrobial solutions.
Halomine™ Inc. is a chemistry-based technology and product company creating innovative solutions that manage surfaces and provide long-term protection against viruses, bacteria, and fungi/mold, in a wide variety of applications. The company’s unique proprietary combinations of specialty molecules and polymers are customized to provide prolonged antimicrobial efficacy to a wide range of surfaces and materials. Halomine’s unique solutions can not only protect against pathogens for weeks or months, but also make surfaces easier to clean, resist adhesion, prevent fouling, and inhibit the formation of biofilms.
FOR MORE INFORMATION CONTACT
Michael Newell, VP Sales and Marketing, Halomine Inc.